Riddhi Siddhi Gluco Biols Limited reported earnings results for the third quarter and nine months ended December 31, 2021. For the third quarter, the company reported sales was INR 1,040.03 million compared to INR 1,272.4 million a year ago. Revenue was INR 1,193.96 million compared to INR 1,417.92 million a year ago. Net loss was INR 76.84 million compared to INR 253.88 million a year ago. Basic loss per share from continuing operations was INR 10.78 compared to INR 35.61 a year ago. Diluted loss per share from continuing operations was INR 10.78 compared to INR 35.61 a year ago.
For the nine months, sales was INR 4,763.08 million compared to INR 2,954.41 million a year ago. Revenue was INR 5,240.58 million compared to INR 3,370.35 million a year ago. Net income was INR 167.79 million compared to net loss of INR 415.42 million a year ago. Basic earnings per share from continuing operations was INR 23.53 compared to basic loss per share from continuing operations of INR 58.27 a year ago. Diluted earnings per share from continuing operations was INR 23.53 compared to diluted loss per share from continuing operations of INR 58.27 a year ago.